EVERYTHING ABOUT API IN PHARMACEUTICAL MANUFACTURING

“The present circumstance has exposed some structural weaknesses in the EU’s medicines source chain in addition to a superior dependence on non-EU international locations for active pharmaceutical ingredients,” Kyriakides explained. She advised that supply chain challenges be resolved in an EU pharmaceutical system predicted for being introdu